Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
17441901000001113 | Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
72641001000001116 | Beconase Hayfever 50micrograms/dose nasal spray (Omega Pharma Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 100 dose | Is pack of | False | Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) | Inferred relationship | Existential restriction modifier | |
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose | Is pack of | False | Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) | Inferred relationship | Existential restriction modifier | |
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 100 dose | Has AMP | True | Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) | Inferred relationship | Existential restriction modifier | |
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose | Has AMP | True | Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets